A previous study showed that administration of recombinant FGF1 effectively improved hepatic inflammation and liver damage in both ob/ob and choline deficient diet-induced mouse models of NAFLD [23]. The gene discussed is FGF1; the disease is metabolic dysfunction-associated steatotic liver disease.